EP Wealth Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$686K Buy
8,761
+219
+3% +$14.9K ﹤0.01% 885
2026
Q1
$552K Sell
8,542
-261
-3% -$18.4K ﹤0.01% 861
2025
Q4
$592K Buy
+8,803
New +$592K ﹤0.01% 805
2025
Q2
$432K Sell
8,303
-72
-0.9% -$4.1K ﹤0.01% 843
2025
Q1
$534K Buy
8,375
+1,606
+24% +$93.3K ﹤0.01% 682
2024
Q4
$324K Buy
6,769
+533
+9% +$27.3K ﹤0.01% 843
2024
Q3
$357K Buy
+6,236
New +$358K ﹤0.01% 800
2024
Q1
Sell
-5,500
Closed -$203K 850
2023
Q4
$203K Sell
5,500
-16
-0.3% -$603 ﹤0.01% 712
2023
Q3
$211K Buy
+5,516
New +$226K ﹤0.01% 656
2023
Q2
Sell
-6,685
Closed -$212K 694
2023
Q1
$212K Buy
6,685
+1,171
+21% +$54.9K ﹤0.01% 562
2022
Q4
$314K Buy
+5,514
New +$282K 0.01% 463
2022
Q3
Sell
-5,500
Closed -$242K 449
2022
Q2
$242K Sell
5,500
-3,000
-35% -$130K 0.01% 534
2022
Q1
$339K Hold
8,500
0.01% 467
2021
Q4
$342K Hold
8,500
0.01% 439
2021
Q3
$346K Hold
8,500
0.01% 405
2021
Q2
$386K Hold
8,500
0.01% 386
2021
Q1
$354K Hold
8,500
0.01% 378
2020
Q4
$363K Hold
8,500
0.01% 319
2020
Q3
$223K Buy
+8,500
New +$237K 0.01% 329
2020
Q2
Sell
-10,000
Closed -$226K 324
2020
Q1
$180K Hold
10,000
0.01% 352
2019
Q4
$177K Hold
10,000
0.01% 402
2019
Q3
$155K Hold
10,000
0.01% 351
2019
Q2
$172K Buy
+10,000
New +$161K 0.01% 301

Other funds holding HALO

EP Wealth Advisors's HALO Position: Q2 2026 in Review

EP Wealth Advisors increased its Halozyme (HALO) stake by 2.6% in Q2 2026, buying an estimated $14.9K and bringing the position to 8,761 shares worth $686K. The position accounts for ﹤0.01% of the portfolio, ranked #885.

EP Wealth Advisors first reported a position in HALO in Q2 2019 and has held it in 23 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • EP Wealth Advisors held 8,761 shares of Halozyme worth $686K as of Q2 2026.
  • EP Wealth Advisors bought 219 Halozyme shares in Q2 2026, an estimated $14.9K.
  • Halozyme made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #885 holding.
  • EP Wealth Advisors first reported a position in Halozyme in Q2 2019 and has held it in 23 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.